JoelMartinCharrowMD
Medical Genetics • Chicago, ILClinical Biochemical Genetics, Clinical Genetics
Professor in Pediatrics, Northwestern University Medical School
Are you Dr. Charrow?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
225 E Chicago Ave
Chicago, IL 60611Phone+1 312-227-6120Fax+1 312-227-9413- Is this information wrong?
Summary
- Dr. Joel Charrow, MD is a board certified medical geneticist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois. He is affiliated with Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern Memorial Hospital.
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1976 - 1981
Icahn School of Medicine at Mount SinaiClass of 1976
Certifications & Licensure
IL State Medical License 1977 - 2026- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
- Open-Label Phase 3 Long-Term Safety Study of Migalastat Start of enrollment: 2011 Oct 14
- Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease Start of enrollment: 2015 Mar 14
Publications & Presentations
PubMed
- 1 citationsVosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.Ravi Savarirayan, William R Wilcox, Paul Harmatz, John Phillips 3rd, Lynda E Polgreen, Louise Tofts, Keiichi Ozono, Paul Arundel, Melita Irving, Carlos A Bacino, Donal...> ;The Lancet. Child & Adolescent Health. 2024 Jan 1
- 1 citationsTreatment-naive and post-treatment glucosylsphingosine (lyso-GL1) levels in a cohort of pediatric patients with Gaucher disease.Carly A Rasmussen, Allegra Quadri, Erika Vucko, Katherine Kim, Rachel Hickey, Joshua J Baker, Joel Charrow, Carlos E Prada> ;Molecular Genetics and Metabolism. 2024 Jan 1
- The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substr...Pramod K Mistry, Priya S Kishnani, Manisha Balwani, Joel M Charrow, Judy Hull, Neal J Weinreb, Timothy M Cox> ;Journal of Clinical Medicine. 2023 May 4
- Join now to see all
Press Mentions
Children with Achondroplasia Could Increase Bone Growth with Novel DrugOctober 27th, 2020
Experimental Drug Can Encourage Bone Growth in Children with DwarfismJune 18th, 2019
Professional Memberships
- Fellow
Hospital Affiliations
Northwestern Memorial HospitalChicago, Illinois
Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Illinois
